Back to top
more

P10 (PX)

(Delayed Data from NYSE)

$7.55 USD

7.55
1,143,254

+0.09 (1.21%)

Updated Apr 29, 2024 04:00 PM ET

After-Market: $7.55 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 252)

Industry: Financial - Miscellaneous Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

MidCap Financial Investment (MFIC) Surpasses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

MidCap Financial (MFIC) delivered earnings and revenue surprises of 16.22% and 2.80%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

StoneX Group Inc. (SNEX) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

StoneX Group Inc. (SNEX) delivered earnings and revenue surprises of 21.13% and 18.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

P10, Inc. (PX) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

P10, Inc. (PX) delivered earnings and revenue surprises of 5% and 3.58%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Royalty Pharma (RPRX) Surpasses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Royalty Pharma (RPRX) delivered earnings and revenue surprises of 2.82% and 3.28%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

PJT Partners (PJT) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

PJT Partners (PJT) delivered earnings and revenue surprises of 10.34% and 13.23%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Does P10, Inc. (PX) Have the Potential to Rally 37% as Wall Street Analysts Expect?

by Zacks Equity Research

The mean of analysts' price targets for P10, Inc. (PX) points to a 36.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Sanghamitra Saha headshot

Global Oil Price War Begins: ETFs in Focus

by Sanghamitra Saha

Declining demand and OPEC+ producers' inability to crack an output cut deal dragged down oil prices and triggered a price war. These ETFs should be watched closely.

Chemical Stock Earnings Slated for Oct 25: PX, EMN & AXTA

by Zacks Equity Research

Investors should check these chemical stocks before their quarterly results as the industry is expected to sustain the momentum in Q3.

Praxair (PX) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Praxair's (PX) third-quarter 2018 results likely to be impacted by currency headwind, inflation, as well as rising freight and logistics costs.

Praxair (PX) Q3 Earnings Preview: What to Know Ahead of the Release

by Zacks Equity Research

Praxair (PX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

KOP vs. PX: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

KOP vs. PX: Which Stock Is the Better Value Option?

Praxair (PX) Scales 52-Week High: What's Driving the Rally?

by Zacks Equity Research

Anticipated merger with Linde, solid backlog and new order wins will likely drive Praxair's (PX) share-price performance in the near term.

    KOP vs. PX: Which Stock Is the Better Value Option?

    by Zacks Equity Research

    KOP vs. PX: Which Stock Is the Better Value Option?

      Should You Invest in the Fidelity MSCI Materials Index ETF (FMAT)?

      by Zacks Equity Research

      Sector ETF report for FMAT

        Why Praxair (PX) is a Top Dividend Stock for Your Portfolio

        by Zacks Equity Research

        Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Praxair (PX) have what it takes? Let's find out.

          Praxair & Linde to Sell Assets for U.S. Antitrust Approval

          by Zacks Equity Research

          CVC and Messer Group to buy additional assets worth $200 million in order to comply with U.S. antitrust approval for the pending Praxair (PX) and Linde merger.

            KOP vs. PX: Which Stock Is the Better Value Option?

            by Zacks Equity Research

            KOP vs. PX: Which Stock Is the Better Value Option?

              Praxair to Benefit From New Order Wins Despite Rising Costs

              by Zacks Equity Research

              Strong backlog, new order wins and focus on capital allocation to drive Praxair's (PX) performance in the near term despite certain challenges.

                Praxair (PX) & Linde Merger Obtains EU Antitrust Approval

                by Zacks Equity Research

                Praxair (PX) and Linde merger receives EU antitrust regulators' approval, taking a step forward for creation of a leading industrial gas company.

                  Company News For Aug 21, 2018

                  by Zacks Equity Research

                  Companies In The News are: EL,COP,PX,AMRX

                    Here's Why You Should Hold on to Praxair (PX) Stock for Now

                    by Zacks Equity Research

                    Praxair (PX) to gain from growing energy and industrial end markets, strong backlog and new order wins despite concerns in Brazilian economy and a strong U.S. dollar.

                      Should You Invest in the Fidelity MSCI Materials Index ETF (FMAT)?

                      by Zacks Equity Research

                      Sector ETF report for FMAT

                        Sweta Killa headshot

                        Material ETFs Gaining on Solid Q2 Earnings

                        by Sweta Killa

                        Given the upbeat results, material ETFs that have the top 10 holdings in these chemical titans performed well in the past 10 days.

                          Praxair (PX) Q1 Earnings & Revenues Top Estimates, Up Y/Y

                          by Zacks Equity Research

                          Praxair's (PX) 2018 performance will benefit from encouraging economic activity and strong backlog.

                            Praxair (PX) Beats Earnings and Revenues Estimates in Q2

                            by Zacks Equity Research

                            Praxair (PX) is expected to gain from positive economic activity and strong backlog.